Physician profile
Sarah Pingar
NPI 1790260115
$521.05
in general payments reported to CMS, 2019-2025
11 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $53.58 · 2022: $256 · 2023: $13.88 · 2024: $46.82 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $211.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $100.62 | 2025 | Cresemba |
| Atricure, INC. | $96.12 | 2022-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Abiomed | $88.18 | 2022 | |
| Nxstage Medical, INC. | $43.83 | 2022 | |
| Chiesi USA, INC. | $36.32 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $33.18 | 2025 | |
| Boston Scientific Corporation | $32.02 | 2021 | |
| Edwards Lifesciences Corporation | $30.08 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.82 | 2024 | Lifevest |
| La Jolla Pharmaceutical Company | $21.00 | 2024 | Giapreza |
| Getinge USA Sales, LLC | $13.88 | 2023 | Vasoview Hemopro 2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Pingar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.